Miguel Quinones-Mateu
Affiliations: | Cleveland State University, Cleveland, OH, United States |
Area:
Virology Biology, Molecular BiologyGoogle:
"Miguel Quinones-Mateu"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Saha T, Sinha S, Harfoot R, et al. (2023) Spray-Dried Inhalable Microparticles Combining Remdesivir and Ebselen against SARS-CoV-2 Infection. Pharmaceutics. 15 |
| Slama L, Hardy WD, Quiñones-Mateu ME, et al. (2023) Alternative options for treatment-experienced people with HIV. Aids (London, England). 37: 1165-1166 |
| Joussef-Piña S, Nankya I, Nalukwago S, et al. (2022) Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in Uganda. Retrovirology. 19: 1 |
| Lawley B, Grant J, Harfoot R, et al. (2021) Rapid Response to SARS-CoV-2 in Aotearoa New Zealand: Implementation of a Diagnostic Test and Characterization of the First COVID-19 Cases in the South Island. Viruses. 13 |
| Ndashimye E, Li Y, Reyes PS, et al. (2021) High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutations. The Journal of Antimicrobial Chemotherapy |
| Datir R, Kemp S, El Bouzidi K, et al. (2020) Emergence of a Novel Protease Inhibitor Resistance Signature in HIV-1 Matrix. Mbio. 11 |
| Ndembi N, Murtala-Ibrahim F, Tola M, et al. (2020) Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria. Aids Research and Therapy. 17: 64 |
| Bonar MM, Tabler CO, Haqqani AA, et al. (2020) Nanoscale flow cytometry reveals interpatient variability in HIV protease activity that correlates with viral infectivity and identifies drug-resistant viruses. Scientific Reports. 10: 18101 |
| Ndashimye E, Avino M, Olabode AS, et al. (2020) Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association |
| Lee ER, Parkin N, Jennings C, et al. (2020) Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing. Scientific Reports. 10: 1634 |